Business

Boston Scientific announces conference call discussing first quarter 2025 results

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the first quarter on April 23 prior to the conference call.

articleBoston Scientific CorporationApril 1, 20251/company/boston-scientific-corp/news/boston-scientific-announces-conference-call-120000114
Boston Scientific announces conference call discussing first quarter 2025 results

About this update from Boston Scientific Corporation

[{"type":"text","content":"MARLBOROUGH, Mass., April 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the first quarter on April 23 prior to the conference call.","length":554,"tagName":"p"},{"type":"image","alt":"Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)","displaySize":"","headline":null,"caption":"Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":209,"url":"https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UMeP4sdxPV_Oy_EDHVZ1lA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM2ODtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888","width":400,"height":209}},"href":"https://mma.prnewswire.com/media/329537/Boston_Scientific_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"A live webcast and replay for the event will be accessible at htts://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.","length":191,"tagName":"p"},{"type":"text","content":"About Boston ScientificBoston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X. ","length":632,"tagName":"p"},{"type":"text","content":"CONTACTS:...

More updates from Boston Scientific Corporation

Boston Scientific Corporationconference callfinancial resultsMike MahoneyDan Brennanchief executive officer